A detailed history of Westpac Banking Corp transactions in Pfizer Inc stock. As of the latest transaction made, Westpac Banking Corp holds 74,198 shares of PFE stock, worth $1.96 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
74,198
Previous 55,973 32.56%
Holding current value
$1.96 Million
Previous $1.57 Billion 37.11%
% of portfolio
0.14%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$27.7 - $31.39 $504,832 - $572,082
18,225 Added 32.56%
74,198 $2.15 Billion
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $1.41 Million - $1.66 Million
55,945 Added 199803.56%
55,973 $1.57 Billion
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $1.34 Million - $1.57 Million
-52,999 Reduced 99.95%
28 $1.57 Billion
Q1 2024

May 09, 2024

SELL
$25.89 - $29.73 $24,569 - $28,213
-949 Reduced 1.76%
53,027 $1.47 Billion
Q4 2023

Feb 08, 2024

SELL
$26.13 - $33.94 $1.06 Million - $1.38 Million
-40,616 Reduced 42.94%
53,976 $1.55 Billion
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $1.43 Million - $1.68 Million
44,699 Added 89.59%
94,592 $3.14 Billion
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $36.1 Million - $41.7 Million
-998,441 Reduced 95.24%
49,893 $1.83 Billion
Q1 2023

May 03, 2023

BUY
$39.39 - $51.28 $5.64 Million - $7.34 Million
143,214 Added 15.82%
1,048,334 $42.8 Billion
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $7.63 Million - $9.96 Million
182,817 Added 25.31%
905,120 $46.4 Billion
Q3 2022

Nov 08, 2022

SELL
$43.76 - $53.42 $3.18 Million - $3.89 Million
-72,765 Reduced 9.15%
722,303 $31.6 Billion
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $1.65 Million - $1.96 Million
-35,485 Reduced 4.27%
795,068 $41.7 Billion
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $2.94 Million - $3.64 Million
64,189 Added 8.38%
830,553 $43 Million
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $4.3 Million - $6.37 Million
104,043 Added 15.71%
766,364 $45.3 Billion
Q3 2021

Oct 27, 2021

SELL
$39.25 - $50.42 $6.73 Million - $8.65 Million
-171,565 Reduced 20.57%
662,321 $28.5 Million
Q2 2021

Aug 11, 2021

SELL
$35.91 - $40.68 $634,134 - $718,368
-17,659 Reduced 2.07%
833,886 $32.7 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $780,317 - $880,041
23,300 Added 2.81%
851,545 $30.9 Million
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $913,597 - $1.16 Million
27,296 Added 3.41%
828,245 $30.5 Million
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $556,704 - $653,141
17,534 Added 2.24%
800,949 $27.9 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $4.58 Million - $5.55 Million
-151,971 Reduced 16.25%
783,415 $24.3 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $155,963 - $222,837
5,770 Added 0.62%
935,386 $29 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $268,989 - $305,268
-8,171 Reduced 0.87%
929,616 $34.6 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $3.12 Million - $4.04 Million
-96,004 Reduced 9.29%
937,787 $32 Million
Q2 2019

Aug 01, 2019

BUY
$36.98 - $41.52 $4.36 Million - $4.9 Million
118,003 Added 12.89%
1,033,791 $0
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $6.6 Million - $7.26 Million
176,130 Added 23.81%
915,788 $0
Q4 2018

Feb 07, 2019

BUY
$38.47 - $43.86 $3.08 Million - $3.51 Million
79,968 Added 12.12%
739,658 $30.6 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $2.01 Million - $2.43 Million
58,235 Added 9.68%
659,690 $0
Q2 2018

Jul 18, 2018

SELL
$32.98 - $35.16 $2.3 Million - $2.45 Million
-69,800 Reduced 10.4%
601,455 $0
Q1 2018

May 01, 2018

BUY
$31.91 - $37.02 $1.03 Million - $1.19 Million
32,155 Added 5.03%
671,255 $0
Q4 2017

Jan 18, 2018

BUY
$33.26 - $35.29 $932,477 - $989,390
28,036 Added 4.59%
639,100 $0
Q3 2017

Oct 30, 2017

BUY
$31.0 - $34.15 $18.9 Million - $20.9 Million
611,064
611,064 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Westpac Banking Corp Portfolio

Follow Westpac Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.